As of September 30, 2024, Aesculap Implant Systems (AIS) will no longer market and distribute products from the Spine portfolio in the United States. Strategic external partnership options for the spine product portfolio, including our unique activL technology, are actively being explored to continue to bring this technology to patients and clinicians after September 30, 2024.
Please contact your AIS sales representative with further questions.
Experience the PlasmaporeXP difference with our entire line of interbody devices
Aesculap offers a comprehensive range of interbody devices to accommodate various cervical and lumbar spinal fusion procedures. Over 50,000 devices implanted since 2012 and still counting.